{
  "retracted": false,
  "timestamp": 1404172800000,
  "updates": [
    {
      "timestamp": 1496036271903,
      "identifier": {
        "doi": "10.1016/j.ygyno.2014.04.048"
      },
      "type": "err"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ygyno.2013.07.081"
  },
  "journal": "Gynecologic Oncology",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to: “Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer” [Gynecol Oncol 131 (2013) 169–173]"
}
